Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

681
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
681
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

521
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
521

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of Three Different Balanced Sedative-Anaesthetic Protocols in Captive Baboons <i>(Papio hamadryas)</i>.

Veterinary sciences·2025
Same author

Multimodal Management of a Descending Aorta Injury with Penetrating Chest Trauma: A Case Report.

Reports (MDPI)·2025
Same author

Comparative analysis of AI algorithms on real medical data for chronic pain detection.

International journal of medical informatics·2025
Same author

Ocular surface microbiome: Influences of physiological, environmental, and lifestyle factors.

Computers in biology and medicine·2025
Same author

Enhancing Chronic Pain Nursing Diagnosis Through Machine Learning: A Performance Evaluation.

Computers, informatics, nursing : CIN·2025
Same author

Flexible Physical Unclonable Functions Based on Non-deterministically Distributed Dye-Doped Fibers and Droplets.

ACS applied materials & interfaces·2024

Related Experiment Video

Updated: Jun 25, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K

Enhancing Thrombophilia Risk Prediction Through AI-Based Methodologies.

Daniela Mazzuca1,2, Francesco Zinno1, Agostino Forestiero3

  • 1Immunohaematology Section, Annunziata Hospital, Cosenza, Italy.

Studies in Health Technology and Informatics
|May 24, 2024
PubMed
Summary

This study introduces an AI-driven approach to predict thrombophilia risk by analyzing diverse patient data. The goal is to improve diagnostic accuracy for this complex clotting disorder.

Keywords:
Artificial IntelligencePersonalized MedicineRisk PredictionThrombophiliaeXplainable AI

More Related Videos

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

8.9K
In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

558

Related Experiment Videos

Last Updated: Jun 25, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

8.9K
In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

558

Area of Science:

  • Biomedical Engineering
  • Computational Biology
  • Medical Diagnostics

Background:

  • Thrombophilia, a predisposition to thrombosis, presents diagnostic challenges due to its multifactorial genetic and acquired causes.
  • Current diagnostic methods struggle to integrate the complex interplay of factors influencing thrombophilia risk.
  • There is a need for advanced, personalized diagnostic tools to accurately assess thrombophilia risk.

Purpose of the Study:

  • To propose an innovative artificial intelligence (AI)-based methodology for enhanced thrombophilia risk prediction.
  • To develop a multidimensional risk assessment model integrating diverse patient data.
  • To achieve advanced and personalized explainable diagnoses for thrombophilia.

Main Methods:

  • Development of an AI-based multidimensional risk assessment model.
  • Integration of comprehensive patient data, including genetic markers, clinical parameters, patient history, and lifestyle factors.
  • Application of AI to elaborate and analyze the integrated data for risk prediction.

Main Results:

  • The AI model successfully integrates heterogeneous patient data for a holistic risk assessment.
  • The methodology facilitates advanced and personalized prediction of thrombophilia risk.
  • Explainable AI outputs provide deeper insights into individual risk profiles.

Conclusions:

  • The proposed AI methodology offers a significant advancement in diagnosing thrombophilia.
  • Multidimensional data integration via AI enhances the accuracy and personalization of risk assessment.
  • This approach holds promise for improving clinical management and patient outcomes in thrombophilia.